Peter Johnson

机构：Cancer Research UK, University Hospital Southampton NHS Foundation Trust, NIHR CRUK Experimental Cancer Medicine Centre, University of Southampton · ORCID：0000-0003-2306-4974

发表论文 1103 篇 · 总被引 39881 次 · h-index 98

代表论文

• Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results (2024 · Journal of Clinical Oncology · 被引 33)
• The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool (2025 · Blood Advances · 被引 9)
• PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient Cohort (2025 · Journal of Nuclear Medicine · 被引 6)
• Involved Field Radiotherapy Versus No Further Treatment in Patients with Newly Diagnosed Stage 1A or 2A Hodgkin Lymphoma and a ‘Negative’ PET Scan after 3 Cycles ABVD. Survival and Cause of Death after a Median of 16 Years Follow-up in the UK RAPID Trial (2024 · Blood · 被引 5)
• Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial (2025 · Blood · 被引 4)
• An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma (2025 · NEJM Evidence · 被引 4)